Searched for
KENTUCKY INJECTABLES FACILITY
How one American brand stays ahead of Trump tariff whac-a-mole. India is part of its planKeen Footwear, despite diversifying its manufacturing locations to mitigate global economic risks, is grappling with the impact of Presiden...- Think ahead about the festive season: 22 stocks whose fortunes are shaped by the festive season; what they say impacts the marketIndia’s consumption year has two currents: The festive-season (Ganesh Chaturthi to Diwali, typically September–November) and the monsoon (J...
- Piramal Pharma deploying USD 85 mn capex this fiscal: Nandini PiramalPiramal Pharma is investing USD 85 million this fiscal for initiatives like capacity expansion and maintenance. They have already used USD ...
- Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facilityPiramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectabl...
- Stocks in news: TCS, Tata Power, IRCTC, Mankind Pharma, Bank of Maharashtra, SpiceJetMankind Pharma announced that it would raise up to Rs 10,000 crore through issuance of non-convertible debentures (NCD) and commercial pape...
- 5 midcap stocks that have beaten volatile markets can rise up to 27%After two weeks of straight upmove,nifty once again witnessed volatile movement last week. In this correction, while the market breadth did...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally up to 55%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ reco which can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Even as bears stay in control of Nifty, midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsNifty in a correction mode and how much time it will stay in that mode, it is anyone's guess. For all those who are busy guessing how thing...
- Coal to crypto: The gold rush bringing bitcoin miners to KentuckyMany large U.S. states have attracted signifiant bitcoin mining investment in recent months, but Kentucky is emerging as a small powerhouse.
- Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaignThe Food and Drug Administration on Friday approved an emergency use authorization for Moderna's vaccine, the second COVID-19 vaccine to re...
- U.S. vaccine campaign launches with first shipments 'delivering hope' to millionsThe coronavirus vaccine, developed by Pfizer and its German partner BioNTech, gained emergency-use approval from federal regulators late on...
- Piramal Enterprises to acquire Ash Stevens Inc for more than Rs 350 crore"Ash Stevens will add high potency capabilities to the services we offer our customers," Vivek Sharma, Pharma Solutions business CEO, Piram...
Load More
